Moderate Versus Aggressive Fluids for Acute Pancreatitis

ClinicalTrials.gov ID: NCT01761539

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01761539. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Moderate Versus Aggressive Fluid Therapy in Patient With Mild to Moderate Acute Pancratitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Fluid resuscitation for pancreatitis is recommended given evidence that hemoconcentration is associated with necrosis. However, there is insufficient evidence to support whether resuscitation should be moderate or aggressive. In this study the investigators aim to compare the clinical outcome associated with these strategies in a clinical randomized fashion to determine the optimal treatment of acute pancreatitis.

Study identification

NCT ID: NCT01761539
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: University of Southern California; Other
Enrollment: 60 participants

Conditions and interventions

Conditions

Pancreatitis

Interventions

Aggressive Hydration Other
Moderate Hydration Other

Other

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2013 (Type not available)
Primary completion: Nov 2015 (Actual)
Completion: Nov 2015 (Actual)
Last update posted: Aug 2, 2016

2013 – 2015

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Los Angeles County Hospital	Los Angeles	California	90033	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01761539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 2, 2016 · Synced Nov 15, 2026